灵康药业集团股份有限公司关于不向下修正“灵康转债”转股价格的公告

Group 1 - The company has decided not to exercise the downward adjustment of the conversion price for "Lingkang Convertible Bonds" despite triggering conditions due to stock price performance [2][6][36] - The current conversion price is set at 6.50 yuan per share, down from the initial price of 8.81 yuan per share, with previous adjustments made due to profit distribution and other factors [3][4][5] - The board will reassess the situation after a three-month period, from January 31, 2026, to April 30, 2026, and will hold another meeting if the adjustment conditions are triggered again [2][6][36] Group 2 - The company plans to change the purpose of repurchased shares from a 50% allocation for employee stock ownership plans and 50% for equity incentives to cancellation and reduction of registered capital [8][10][12] - A total of 8,915,893 shares, representing 1.24% of the company's total share capital, will be canceled as part of this plan [9][13] - The decision to change the purpose of repurchased shares is aimed at enhancing long-term investor confidence and improving earnings per share [12][14][38]